| FSTCX | FTUAX | FSTCX / FTUAX | |
| Total Expense Ratio | 0.75 | 1.05 | 71% |
| Annual Report Gross Expense Ratio | 0.75 | 1.05 | 71% |
| Fund Existence | 40 years | 19 years | - |
| Gain YTD | 11.845 | 11.565 | 102% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | 500 | 500 | 100% |
| Net Assets | 235M | 235M | 100% |
| Annual Yield % from dividends | 2.49 | 2.27 | 109% |
| Returns for 1 year | 8.98 | 8.66 | 104% |
| Returns for 3 years | 38.19 | 36.97 | 103% |
| Returns for 5 years | -4.76 | -6.30 | 76% |
| Returns for 10 years | 12.64 | 10.52 | 120% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ETHSX | 13.98 | 0.16 | +1.16% |
| Eaton Vance Worldwide Health Sci A | |||
| EMAYX | 18.85 | 0.03 | +0.16% |
| Gabelli Entpr Mergers & Acquisitions Y | |||
| DESSX | 26.98 | 0.02 | +0.07% |
| DWS ESG Core Equity S | |||
| OSCYX | 23.68 | -0.03 | -0.13% |
| Invesco Main Street Small Cap Y | |||
| SLCCX | 41.44 | -0.15 | -0.36% |
| ClearBridge Large Cap Growth C | |||